Glyburide Not Noninferior to Insulin for Gestational Diabetes
TUESDAY, May 1, 2018 -- For women with gestational diabetes, glyburide is not noninferior to insulin, according to a study published in the May 1 issue of the Journal of the American Medical Association. Marie-Victoire S énat, M.D., Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Glyburide Should Not Be First-Line for Gestational Diabetes Glyburide Should Not Be First-Line for Gestational Diabetes
Noninferiority study suggests glyburide may be associated with up to a 10.5% increase in perinatal complications compared with insulin treatment of gestational diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 1, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

What's the Best First-Line Tx for Gestational Diabetes? (CME/CE)
(MedPage Today) -- Glyburide versus subcutaneous insulin did not result in a greater frequency of perinatal complications (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 1, 2018 Category: Cardiology Source Type: news

Glucovance (Glyburide and Metformin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 21, 2017 Category: Drugs & Pharmacology Source Type: news

Micronase (Glyburide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 21, 2017 Category: Drugs & Pharmacology Source Type: news

Glynase PresTab (Micronized Glyburide Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 21, 2017 Category: Drugs & Pharmacology Source Type: news

Mylan launches first generic EpiPen as state AGs sue generics makers for price collusion
Mylan (NSDQ:MYL) launched its 1st generic EpiPen emergency allergy treatment 1 day after attorney generals from 20 states filed a civil complaint against Mylan, Teva Pharmaceuticals (NYSE:TEVA), and 4 other generic drug makers. The complaint alleges that the companies co-conspired in informal gatherings, calls and text messages to fix the price for glyburide, a diabetes drug, and doxycycline hyclate, an antibiotic. The Canonsburg, Penn.-based company has been under fire since August when reports revealed it hiked the price of its EpiPen device 500% since it acquired the auto-injector in 2007. In response to ...
Source: Mass Device - December 16, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Legal News Pharmaceuticals Wall Street Beat Heritage Pharmaceuticals Mylan Teva Pharmaceuticals Source Type: news

Ex pharma execs first to be charged in generic drug pricing case
Former Heritage Pharmaceuticals CEO Jeffrey Glazer and ex-president Jason Malek were hit yesterday with the 1st criminal charges from a 2-year federal investigation in an ongoing generic drug pricing case. The 2 former executives were charged by federal authorities with price collusion for doxycycline hyclate, a widely used antibiotic, and a diabetes therapy called glyburide from 2013 and 2015. Other drug makers have reportedly received subpoenas as a part of the U.S. Justice Dept. probe. Bloomberg News reported that Mylan (NSDQ:MYL), Teva Pharmaceuticals (NYSE:TEVA), and Endo International’s Par subsidiary are among...
Source: Mass Device - December 15, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Legal News Pharmaceuticals Wall Street Beat Dept. of Justice (DOJ) Heritage Pharmaceuticals Mylan Teva Pharmaceuticals Source Type: news

US generics probe reveals startling detail of price fixing in Doxycycline and Glyburide
A Bloomberg report said two executives of Heritage Pharma – the US arm of Indian drug maker Emcure - are preparing to plead guilty to price-fixing charges while assuring cooperation with US prosecutors. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 15, 2016 Category: Pharmaceuticals Source Type: news

Glucovance (glyburide/metformin)
Title: Glucovance (glyburide/metformin)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 8/31/2016 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - August 31, 2016 Category: Endocrinology Source Type: news

Phase III trial planned for drug to reduce brain swelling from stroke
Intravenous glyburide, designed to limit brain swelling in stroke patients, did not reduce the number of emergency surgeries in a Phase II clinical trial but did show promise in improving patient outcomes, according to a study published online Aug. 23 in the journal Lancet Neurology. (Source: Yale Science and Health News)
Source: Yale Science and Health News - August 23, 2016 Category: Universities & Medical Training Tags: Yale News Source Type: news

Zydus Cadila gets USFDA nod for anti-diabetics tablets
Drug firm Zydus Cadila has received final nod from the US health regulator to sell anti-diabetics Glyburide and Metformin Hcl tablets in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2016 Category: Pharmaceuticals Source Type: news

GAMES-RP: Can Glyburide Reduce Edema in Severe Stroke? GAMES-RP: Can Glyburide Reduce Edema in Severe Stroke?
A new IV formulation of the generic diabetes drug shows some promising effects on exploratory endpoints in a phase 2 study of patients with large hemispheric stroke. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 24, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Cancer Risk Elevated With Glyburide Over Other Sulfonylureas Cancer Risk Elevated With Glyburide Over Other Sulfonylureas
Overall cancer risk with glyburide was not significantly elevated, but significant dose- and duration-response relationships were seen with glyburide and breast, prostate, and colorectal cancers. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2015 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

glyburide/metformin (Glucovance)
Title: glyburide/metformin (Glucovance)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 8/20/2015 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - August 20, 2015 Category: Endocrinology Source Type: news

Diabetes Tx Ups Risk for Poor Neonatal Outcomes (CME/CE)
(MedPage Today) -- Study heightens residual concerns about use of glyburide to treat gestational diabetes. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 1, 2015 Category: Cardiology Source Type: news

Glyburide Tied to Greater Neonatal Risk Than Insulin in GDMGlyburide Tied to Greater Neonatal Risk Than Insulin in GDM
The largest study to date of glyburide vs insulin for gestational diabetes identifies an increased risk of adverse neonatal outcomes with glyburide; however, insulin may not be best for all women. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 1, 2015 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Glyburide Treatment for Gestational Diabetes Associated with Adverse Newborn Health Effects (FREE)
By Jenni Whalen Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Treating gestational diabetes with glyburide, rather than insulin, is associated with increased risk for adverse outcomes in newborns, according to a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 31, 2015 Category: Primary Care Source Type: news

Gestational Diabetes Drug Might Raise Babies' Complication Risk
Study links glyburide to more infant intensive care and respiratory distress (Source: WebMD Health)
Source: WebMD Health - March 30, 2015 Category: Consumer Health News Source Type: news

Gestational Diabetes Drug Might Raise Babies' Complication Risk
Study links glyburide to more infant intensive care and respiratory distress Source: HealthDay Related MedlinePlus Pages: Diabetes and Pregnancy, Pregnancy and Medicines, Uncommon Infant and Newborn Problems (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 30, 2015 Category: Consumer Health News Source Type: news

Short-Term Outcomes Worse With Glyburide for GDMShort-Term Outcomes Worse With Glyburide for GDM
Glyburide (glibenclamide) should not be used to treat gestational diabetes mellitus (GDM) unless insulin and metformin are unavailable, the authors of a new systematic review and meta-analysis conclude. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 2, 2015 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Glyburide Seems a Poor Choice in Gestational Diabetes (FREE)
By Joe Elia Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS The oral agent glyburide is "clearly inferior" to both metformin and insulin in gestational diabetes outcomes, a BMJ meta-analysis … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 23, 2015 Category: Primary Care Source Type: news

glyburide
Title: glyburideCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/29/2014 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 29, 2014 Category: Drugs & Pharmacology Source Type: news

glyburide
Title: glyburideCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/29/2014 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - October 29, 2014 Category: Endocrinology Source Type: news

Common heart drug's link to diabetes uncovered by researchers
Statins activated a very specific immune response, which stopped insulin from doing its job properly, researchers have found. They connected the dots and found that combining statins with another drug on top of it, Glyburide, suppressed this side effect. Approximately 13 million people, or half of those over the age of 40, could be prescribed a statin drug in their lifetime. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 11, 2014 Category: Science Source Type: news